What is ARA-290?
ARA-290, also called cibinetide, is an erythropoietin-derived peptide researched for tissue-protective and anti-inflammatory signaling without the red-blood-cell effects associated with full erythropoietin.
Interest usually comes from neuropathy, nerve repair, inflammatory pain, and recovery communities. Supplier comparison should focus on product-specific COA/HPLC visibility, clear vial size, shipping reliability, and whether the vendor already has review or catalogue evidence on VialVerdict.
How it works
- Studied for innate repair receptor signaling connected to tissue protection and inflammation modulation.
- Research models often focus on neuropathic pain, small-fiber neuropathy, tissue injury, and immune-inflammatory pathways.
- Vendor trust matters because ARA-290 buyers often compare smaller specialist suppliers rather than only large peptide catalogues.
Primary effects
- Neuropathy research
- Anti-inflammatory signaling
- Tissue-protection models
- Recovery and nerve-repair research
Common side effects
- Injection-site irritation
- Human side-effect data is limited
- Unknown long-term risk profile outside studied settings